Cytokinetics Inc (CYTK)       41  +1.71 (+4.35%)

41  +1.71 (+4.35%)

US23282W6057 - Common Stock - After market: 40.97 -0.03 (-0.07%)

Cytokinetics Inc41

NASDAQ:CYTK (7/1/2022, 7:08:09 PM)+1.71 (+4.35%)

After market: 40.97 -0.03 (-0.07%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS Sector Health Care
GICS Industry Biotechnology
Chartmill FA Rating
Valuation Growth
Profitability Health
Dividend
Overview
Earnings (Last) 05-04 2022-05-04/amc Earnings (Next) 08-03 2022-08-03
Ins Owners 1.29% Inst Owners 111.57%
Market Cap 3.51B Shares 85.65M
PE N/A Fwd PE N/A
Dividend Yield N/A Analysts 83.16
IPO 04-29 2004-04-29

Stock Screener Links

Screen Image

Nasdaq Stock Screener

Find more stocks on Nasdaq

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

CYTK Daily chart

Company Profile

Cytokinetics, Inc. operates as a biopharmaceutical company. The company is headquartered in South San Francisco, California and currently employs 253 full-time employees. The company went IPO on 2004-04-29. The company is focused on discovering, developing, and commercializing muscle activators and muscle inhibitors as potential treatments for debilitating diseases. The company is developing small molecule drug candidates specifically engineered to impact muscle function and contractility. Its clinical-stage drug candidates are: omecamtiv mecarbil, a cardiac myosin activator for the treatment of heart failure with reduced ejection fraction (HFrEF); CK-136, a cardiac troponin activator for the treatment of heart failure and other diseases; reldesemtiv (CK-2127107), a fast skeletal muscle troponin activator (FSTA) for the treatment of people living with debilitating diseases and conditions associated with muscular weakness; aficamten (CK-274), a cardiac myosin inhibitor designed to reduce the hypercontractility that is associated with hypertrophic cardiomyopathy (HCM); and CK-3772271 (CK-271), a second novel cardiac myosin inhibitor.

Company Info

Cytokinetics Inc

., 280 East Grand Avenue

South San Francisco CALIFORNIA 94080

P: 16506243000.0

CEO: Robert I. Blum

Employees: 253

Website: http://cytokinetics.com/

News

News Image4 days ago - Cytokinetics, IncorporatedCytokinetics Announces Pricing of $450 Million Convertible Senior Notes Offering

SOUTH SAN FRANCISCO, Calif., July 01, 2022 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (“Cytokinetics”) (Nasdaq: CYTK) today announced the pricing of...

News Image4 days ago - ChartmillThursday's after hours session: top gainers and losers

The US market regular session of Thursday is over, let's have a look at the top gainers and losers in the after hours session today.

News Image5 days ago - ChartmillThese stocks are moving in today's pre-market session

The US market session of Thursday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today.

News Image5 days ago - ChartmillWhich stocks are moving after the closing bell on Wednesday?

Let's have a look at what is happening on the US markets after the closing bell on Wednesday. Below you can find the top gainers and losers in today's after hours session.

News Image5 days ago - Cytokinetics, IncorporatedCytokinetics Announces Proposed Convertible Senior Notes Offering

SOUTH SAN FRANCISCO, Calif., June 29, 2022 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (“Cytokinetics”) (Nasdaq: CYTK) today announced its intention...

CYTK Twits

Here you can normally see the latest stock twits on CYTK, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example